Kalydeco (ivacaftor) is a drug used to treat cystic fibrosis, a disorder that affects many organs, particularly the lungs. Cystic fibrosis is Australia's most commonly inherited disorder.
May 3, 2017
0
0
A quarter of a century ago, the physicist, physician and cell biologist Professor Thomas Jentsch and his research team opened up an entirely new field of research in the field of ion transport. Now the British journal The ...
Sep 15, 2015
0
18
A team of UBC researchers has made a significant discovery uncovering the cause of brain swelling after trauma to the head. Their research, published today in Cell, paves the way for a preventative drug treatment for severe ...
Apr 23, 2015
0
17
In diseases such as asthma and chronic obstructive pulmonary disease (COPD), the body produces too much mucus, making breathing difficult. New research from Washington University School of Medicine in St. Louis provides clues ...
Mar 18, 2015
0
20
Several forms of leukodystrophies, genetic degenerative disorders that affect the myelin, are associated with vacuolization of myelin sheaths that enwrap axons of central neurons. Megalencephalic leukoencephalopathy (MLC), ...
Mar 26, 2014
0
0
A drug developed to treat genetic diseases such as Duchenne muscular dystrophy and cystic fibrosis may need a radical rethink. In a new study published on 25 June in the open access journal PLOS Biology, researchers question ...
Jun 25, 2013
0
0
(Medical Xpress)—A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found ...
Mar 21, 2013
0
0
A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding ...
Sep 17, 2012
0
0
A recent study led by Gergely Lukacs, a professor at McGill University's Faculty of Medicine, Department of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene ...
Mar 12, 2012
0
0
A team of academic researchers has identified the intracellular mechanisms regulated by vitamin D3 that may help the body clear the brain of amyloid beta, the main component of plaques associated with Alzheimer's disease.
Mar 6, 2012
0
0
